Exploring the Immune Modulatory Effects of Regorafenib for the Treatment of Head and Neck Squamous Cell Carcinoma-Therapeutic Implication

Project title

探討多激酶抑制劑Regorafenib在頭頸癌的免疫調節作用: 治療學意義之探討

Internal ID

109-2314-B-002-057-MY3

Principal Investigator

Start Date

August 1, 2021

End Date

July 31, 2022

Investigators

Organizations

Partner Organizations

National Science and Technology Council